Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/SLS/Revenue

SELLAS Life Sciences Group, Inc. (SLS) Revenue 2019–2023

SELLAS Life Sciences Group, Inc. (SLS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$0FY2023 · since FY2019: $0 → $0
1920212223
Fiscal yearValueYoY
FY2023$0-100.0%
FY2022$1.0M-86.8%
FY2021$7.6M+300.0%
FY2020$1.9M—
FY2019$0—

Source: SEC XBRL filings · For reference only · Not investment advice

More SLS financial trends

SLS Net incomeSLS Net marginSLS Gross profitSLS Gross marginSLS Operating incomeSLS Operating marginSLS Operating cash flowSLS Free cash flowSLS Capital expendituresSLS Return on equitySLS Stock buybacksSLS Dividends paidSLS Total assetsSLS Total liabilitiesSLS Shareholders’ equitySLS overview →